(Q44136363)

30 November 2017

title

Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension (English)

1 reference

30 November 2017

John J Lepore

1

1 reference

30 November 2017

Anjli Maroo

2

1 reference

30 November 2017

Naveen L Pereira

3

1 reference

30 November 2017

Leo C Ginns

4

1 reference

30 November 2017

G William Dec

5

1 reference

30 November 2017

Warren M Zapol

6

1 reference

30 November 2017

Kenneth D Bloch

7

1 reference

30 November 2017

Marc J Semigran

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

American Journal of Cardiology

30 November 2017

published in

1 reference

30 November 2017

volume

90

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

677-680

1 reference

Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Inhaled nitric oxide: basic biology and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Cyclic GMP phosphodiesterase-5: target of sildenafil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil inhibits hypoxia-induced pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil can increase the response to inhaled nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Sildenafil (viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Hemodynamic effects of inhaled nitric oxide in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Hemodynamic effects of sildenafil in men with severe coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

Effects of sildenafil citrate on human hemodynamics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902586-9

10.1016/S0002-9149(02)02586-9

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference